The Decipher Bladder test identifies aggressive bladder cancer, aiding in treatment decisions beyond initial clinical staging. Non-luminal tumors in NMIBC show higher upstaging rates to MIBC and ...

From 2004-2009 to 2016-2020, the proportion of patients found to have high-risk and intermediate-risk prostate cancer after upfront radical prostatectomy increased from 16% to 27% and from 55% to 60%, ...

Please provide your email address to receive an email when new articles are posted on . Patients with upstaged tumors saw an overall mortality rate of 36% vs. 19.5% in their non-upstaged counterparts.

Lymphovascular invasion in RCC is associated with upstaging and worse survival outcomes. Patients with lymphovascular invasion are at increased risk for renal cell carcinoma (RCC) upstaging and worse ...

Liposome-Encapsulated Doxorubicin in Combination With Standard Agents (cyclophosphamide, vincristine, prednisone) in Patients With Newly Diagnosed AIDS-Related Non-Hodgkin's Lymphoma: Results of ...

Please provide your email address to receive an email when new articles are posted on . Delaying follow-up after receipt of positive lung cancer screening findings was relatively common. Patients with ...

Outcomes of additional BCG versus sequential gemcitabine + docetaxel in BCG-exposed high-risk non–muscle-invasive bladder cancer. Non-muscle invasive bladder cancer burden: The impact of BCG shortage ...